123 related articles for article (PubMed ID: 23963727)
1. Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury.
Fang F; Chen D; Yu L; Dai X; Yang Y; Tian W; Cheng X; Xu H; Weng X; Fang M; Zhou J; Gao Y; Chen Q; Xu Y
Circ Res; 2013 Sep; 113(8):986-96. PubMed ID: 23963727
[TBL] [Abstract][Full Text] [Related]
2. SMARCA4 (BRG1) activates ABCC3 transcription to promote hepatocellular carcinogenesis.
Liu H; Yue L; Hong W; Zhou J
Life Sci; 2024 Jun; 347():122605. PubMed ID: 38642845
[TBL] [Abstract][Full Text] [Related]
3. PROTACs Targeting BRM (SMARCA2) Afford Selective
Berlin M; Cantley J; Bookbinder M; Bortolon E; Broccatelli F; Cadelina G; Chan EW; Chen H; Chen X; Cheng Y; Cheung TK; Davenport K; DiNicola D; Gordon D; Hamman BD; Harbin A; Haskell R; He M; Hole AJ; Januario T; Kerry PS; Koenig SG; Li L; Merchant M; Pérez-Dorado I; Pizzano J; Quinn C; Rose CM; Rousseau E; Soto L; Staben LR; Sun H; Tian Q; Wang J; Wang W; Ye CS; Ye X; Zhang P; Zhou Y; Yauch R; Dragovich PS
J Med Chem; 2024 Jan; 67(2):1262-1313. PubMed ID: 38180485
[TBL] [Abstract][Full Text] [Related]
4. Redox-sensitive activation of CCL7 by BRG1 in hepatocytes during liver injury.
Kong M; Dong W; Zhu Y; Fan Z; Miao X; Guo Y; Li C; Duan Y; Lu Y; Li Z; Xu Y
Redox Biol; 2021 Oct; 46():102079. PubMed ID: 34454163
[TBL] [Abstract][Full Text] [Related]
5. The endothelial-enriched lncRNA LINC00607 mediates angiogenic function.
Boos F; Oo JA; Warwick T; Günther S; Izquierdo Ponce J; Lopez M; Rafii D; Buchmann G; Pham MD; Msheik ZS; Li T; Seredinski S; Haydar S; Kashefiolasl S; Plate KH; Behr R; Mietsch M; Krishnan J; Pullamsetti SS; Bibli SI; Hinkel R; Baker AH; Boon RA; Schulz MH; Wittig I; Miller FJ; Brandes RP; Leisegang MS
Basic Res Cardiol; 2023 Jan; 118(1):5. PubMed ID: 36700983
[TBL] [Abstract][Full Text] [Related]
6. Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism.
Tsujikawa LM; Fu L; Das S; Halliday C; Rakai BD; Stotz SC; Sarsons CD; Gilham D; Daze E; Wasiak S; Studer D; Rinker KD; Sweeney M; Johansson JO; Wong NCW; Kulikowski E
Clin Epigenetics; 2019 Jul; 11(1):102. PubMed ID: 31300040
[TBL] [Abstract][Full Text] [Related]
7. The glycocalyx core protein Glypican 1 protects vessel wall endothelial cells from stiffness-mediated dysfunction and disease.
Mahmoud M; Mayer M; Cancel LM; Bartosch AM; Mathews R; Tarbell JM
Cardiovasc Res; 2021 May; 117(6):1592-1605. PubMed ID: 32647868
[TBL] [Abstract][Full Text] [Related]
8. Induction of functional Brm protein from Brm knockout mice.
Thompson KW; Marquez SB; Lu L; Reisman D
Oncoscience; 2015; 2(4):349-61. PubMed ID: 26097869
[TBL] [Abstract][Full Text] [Related]
9. Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms.
Bejarano L; Kauzlaric A; Lamprou E; Lourenco J; Fournier N; Ballabio M; Colotti R; Maas R; Galland S; Massara M; Soukup K; Lilja J; Brouland JP; Hottinger AF; Daniel RT; Hegi ME; Joyce JA
Cancer Cell; 2024 Mar; 42(3):378-395.e10. PubMed ID: 38242126
[TBL] [Abstract][Full Text] [Related]
10. Importance of receptor-targeted systems in the battle against atherosclerosis.
Rosas E; Sobenin I; Orekhov A; Edelman ER; Balcells M
Curr Pharm Des; 2013; 19(33):5897-903. PubMed ID: 23438961
[TBL] [Abstract][Full Text] [Related]
11. Discovery of BRM Targeted Therapies: Novel Reactivation of an Anti-cancer Gene.
Gramling S; Reisman D
Lett Drug Des Discov; 2011 Jan; 8(1):93-99. PubMed ID: 23565070
[TBL] [Abstract][Full Text] [Related]
12. Post-transcriptional gene regulation by RNA-binding proteins in vascular endothelial dysfunction.
Xin H; Deng K; Fu M
Sci China Life Sci; 2014 Aug; 57(8):836-44. PubMed ID: 25104457
[TBL] [Abstract][Full Text] [Related]
13. Perpetual change: autophagy, the endothelium, and response to vascular injury.
Sachdev U; Lotze MT
J Leukoc Biol; 2017 Aug; 102(2):221-235. PubMed ID: 28626046
[TBL] [Abstract][Full Text] [Related]
14. More than just a simple barrier.
Velazquez-Miranda E; He M
Elife; 2024 Mar; 13():. PubMed ID: 38533842
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell dysfunction in cardiac disease: driver or consequence?
Allbritton-King JD; García-Cardeña G
Front Cell Dev Biol; 2023; 11():1278166. PubMed ID: 37965580
[TBL] [Abstract][Full Text] [Related]
16. BRM Targeting Compounds for the Potential Treatment of Cancer.
Kargbo RB
ACS Med Chem Lett; 2020 Feb; 11(2):99-100. PubMed ID: 32071673
[No Abstract] [Full Text] [Related]
17. Superfamily II helicases: the potential therapeutic target for cardiovascular diseases.
Fang T; Wang X; Huangfu N
Front Cardiovasc Med; 2023; 10():1309491. PubMed ID: 38152606
[TBL] [Abstract][Full Text] [Related]
18. Targetable Brg1-CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking.
Li N; Liu H; Xue Y; Xu Z; Miao X; Guo Y; Li Z; Fan Z; Xu Y
EMBO Mol Med; 2023 Mar; 15(3):e16592. PubMed ID: 36722664
[TBL] [Abstract][Full Text] [Related]
19. MiR-199a-5p-containing macrophage-derived extracellular vesicles inhibit SMARCA4 and alleviate atherosclerosis by reducing endothelial cell pyroptosis.
Liang W; Chen J; Zheng H; Lin A; Li J; Wu W; Jie Q
Cell Biol Toxicol; 2023 Jun; 39(3):591-605. PubMed ID: 35930100
[TBL] [Abstract][Full Text] [Related]
20. Trans-activation of eotaxin-1 by Brg1 contributes to liver regeneration.
Fan Z; Kong M; Dong W; Dong C; Miao X; Guo Y; Liu X; Miao S; Li L; Chen T; Qu Y; Yu F; Duan Y; Lu Y; Zou X
Cell Death Dis; 2022 May; 13(5):495. PubMed ID: 35614068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
